Adjusted Operating Income within Guidance; Organic Growth and Favorable Product Mix in Industrial and Rail Offset Bad Debt Costs in Metals & Minerals Project Orion Execution Progressing Rapidly with Phase I Benefits Expected to Reach High-end of Expectations Company Narrows 2014 Adjusted Operating Income Guidance to Range of $170 million to $180 million CAMP HILL, Pa., Aug.
NRG Energy, Inc. (NYSE:NRG) today reported second quarter 2014 Adjusted
EBITDA of $671 million with Wholesale contributing $389 million, Retail
contributing $173 million and NRG Yield contributing $109 million.
Revenues were $1.72 billion for the second quarter of 2014
Segment operating margin was 9.5 percent, a 140 bps improvement over Q2 2013
Total operating margin was 10.5 percent, up from 6.9 percent in the same period last year
Diluted earnings per share was $2.04 for the quarter
Pension-adjusted diluted earnings per share was $1.75 for the quarter
Cash and cash equivalents at the end of the quarter were $592 million
NEWPORT NEWS, Va., Aug.
Chesapeake Granite Wash Trust (NYSE:CHKR) (the “Trust”) today announced
that its common unit distribution for the quarter ended June 30, 2014
(which primarily relates to production attributable to the Trust’s
royalty interests from March 1, 2014 through May 31, 2014) will be
$0.5796 per common unit.
Cincinnati Bell Inc. (NYSE:CBB) announced today that Cincinnati Bell
Telephone Company LLC and the Communications Workers of America (CWA)
have reached a tentative agreement on a new 27-month labor contract.
SOUTH SAN FRANCISCO, CA --
Communications Corporation (NTT Com), the global data and IP
services arm of telecom leader NTT (NYSE: NTT), and RagingWire Data
Centers (RagingWire), the premier data center provider in the United
States and an NTT Communications group company, today announced that NTT
Com has expanded its Tier-1 Global IP Network into RagingWire’s data
center facilities in Ashburn, Virginia, and Sacramento, California.
Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has
submitted a Biologics License Application to the U.S. Food and Drug
Administration (FDA) for Anthrax Immune Globulin Intravenous (Human)
[AIGIV] as part of a development contract with the Biomedical Advanced
Research and Development Authority (BARDA). AIGIV, which was acquired in
the Cangene acquisition completed earlier this year, is being developed
as an intravenous therapeutic treatment for inhalation anthrax.
Global colocation solutions provider CyrusOne (NASDAQ: CONE) is pleased
to announce that it plans to house the infrastructure and 911-dispatch
center for Carrollton, Coppell, Farmers Branch, and Addison, Texas.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.